News

Pershing Square Sohn Cancer Research Alliance Attends the 5th Annual Galien Forum

The Pershing Square Sohn Cancer Research Alliance recently sponsored a panel entitled, “Pioneers for a Cure: the Role of Innovation and Entrepreneurship in Cancer Research” at the 5th Annual Galien Forum.

Read More

On Cancer: Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 17, 2014 – For people with advanced breast cancer, several clinical trials have shown that experimental targeted drugs called PI3K inhibitors can temporarily halt the spread of disease. But eventually the tumors learn to outwit the drugs and begin growing again.

Read More

Google’s Newest Search: Cancer Cells

By Alistair Barr and Ron Winslow (The Wall Street Journal) – Google Inc. is designing tiny magnetic particles to patrol the human body for signs of cancer and other diseases, in the latest example of the Internet giant’s sweeping ambition.

Read More

PRESS RELEASE: Applications Open for the 2015 Pershing Square Sohn Prize for Young Investigators in Cancer Research

New York, October 2, 2014– The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to five New York City-based scientists, enabling them to pursue cutting-edge research at … Continued

Read More

Young, Brilliant and Underfunded

By Andy Harris (The New York Times) WASHINGTON — EVERY year the National Institutes of Health receives almost $30 billion in federal funds to invest in biomedical research. The bulk of that money goes to researchers who are in many cases esteemed in their fields — but also, in many cases, beyond the age when … Continued

Read More

A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia

Abstract: Efforts to identify and annotate cancer driver genetic lesions have been focused primarily on the analysis of protein-coding genes; however, most genetic abnormalities found in human cancer are located in intergenic regions.

Read More

Private Money Pays Off For Medicine

By Eric S. Lander And Louis V. Gerstner Jr. (The Wall Street Journal) – Twenty-six years ago, Ted Stanley found his son, Jonathan, in a straitjacket in a locked psychiatric ward in Manhattan’s Bellevue Hospital.

Read More

Cancer Philanthropy, Wall Street-Style

Kristina Strain (Inside Philanthropy) – This ain’t your father’s cancer philanthropy. This ain’t some namby-pamby Race for the Cure-style charity outfit or a lumbering legacy foundation. This is cancer philanthropy, Wall Street-style.

Read More

PRESS RELEASE: Damon Runyon, Sohn Conference Foundations name 3 new pediatric cancer research fellows

New York, Memphis, Boston scientists receive prestigious awards to tackle cancers in children and young adults New York, NY (June 20, 2014) – The Damon Runyon Cancer Research Foundation has named three outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award, committing nearly $625,000 to help address a critical … Continued

Read More

Is This How We’ll Cure Cancer?

By Matthew Herper (Forbes) – For 85% of kids with a terrible cancer called acute lymphoblastic leukemia, chemotherapy is a cure–but not for Emily Whitehead. Diagnosed at 5, she suffered an infection from her first round of chemo and nearly lost her legs.

Read More